eople who’ve a historical past of “vital” allergic reactions have been instructed to not at the moment take the Pfizer/BioNTech Covid-19 vaccine after two NHS staff who acquired the jab had allergic reactions.
Each are recovering, it’s understood.
After the incident, the Medicines and Healthcare merchandise Regulatory Company (MHRA) issued precautionary recommendation to NHS trusts that anybody who has a historical past of “vital” allergic reactions shouldn’t obtain the vaccine.
This contains reactions to medicines, meals or vaccines.
The NHS in England stated all trusts concerned with the vaccination programme had been knowledgeable.
Professor Stephen Powis, nationwide medical director for the NHS in England, stated: “As is frequent with new vaccines the MHRA have suggested on a precautionary foundation that individuals with a major historical past of allergic reactions don’t obtain this vaccination after two individuals with a historical past of great allergic reactions responded adversely yesterday.
“Each are recovering nicely.”
“It’s my understanding that the Meals and Drug Administration will likely be wanting this week to conclude their evaluation, and the European Medicines Company pretty shortly thereafter,” she instructed the Commons Science and Know-how Committee.
Dr Raine added that she was not in a position to give a “agency date” on when the evaluation of the UK’s “homegrown” Oxford/AstraZeneca vaccine can be accomplished.
“The information packages for the AstraZeneca/Oxford vaccine have been arriving, we do anticipate an additional bundle within the coming days,” she instructed the Commons Science and Know-how and Well being and Social Care committees.
“I’d not be capable to give the committees a agency date, as a result of the evaluation is clearly a really lively evaluation.
“There will likely be questions and deliberations that we are going to be pursuing in precisely the identical manner as now we have finished for Pfizer/BioNTech.
“So, not in a position to give a agency date, however to guarantee the committees that work is continuing intensively and with nice scientific rigour.”